Amanote Research
Register
Sign In
Discovery of Inhibitors of Aurora/PLK Targets as Anticancer Agents
doi 10.1021/acs.jmedchem.9b00353.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Discovery of Small Molecule Integrin Avb3 Antagonists as Novel Anticancer Agents
3d-Qsar Analysis of Pyrimidine Derivatives as AXL Kinase Inhibitors as Anticancer Agents
Journal of Applied Pharmaceutical Science
Medicine
Toxicology
Pharmaceutics
Pharmacology
Discovery of New Anticancer Agents From Higher Plants
Frontiers in Bioscience - Scholar
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Recent Development of ATP-competitive Small Molecule Phosphatidylinostitol-3-Kinase Inhibitors as Anticancer Agents
Oncotarget
Oncology
Discovery and Development of Natural Product Oridonin-Inspired Anticancer Agents
European Journal of Medicinal Chemistry
Medicine
Organic Chemistry
Drug Discovery
Pharmacology
Bacteriocins as Potential Anticancer Agents
Frontiers in Pharmacology
Pharmacology
Benzothiazole Derivatives as Anticancer Agents
Journal of Enzyme Inhibition and Medicinal Chemistry
Medicine
Drug Discovery
Pharmacology
Platinum Intercalators of DNA as Anticancer Agents
European Journal of Inorganic Chemistry
Inorganic Chemistry
Discovery of Potent and Orally Available Malonyl-CoA Decarboxylase Inhibitors as Cardioprotective Agents
